India's CDSCO has approved a new trial for an autoimmune drug by Mankind Pharma, following successful multicentric trials for other medical devices. This development addresses rising needs for treatments amid increasing lifestyle disease deaths. The trial focuses on broad therapeutic applications for autoimmune conditions.
Trial Scope
The drug aims to manage autoimmune disorders effectively, with emphasis on safety and efficacy.
Health Context
Global studies highlight the urgency for innovations in lifestyle-related health issues.